Novavax Inc (NVAX)

EBITDA Margin

-49.68%

TTM · Period ending:

NVAX logo

NVAX EBITDA Margin

Latest reported-49.68%
NVAX TTM EBITDA Margin (-1600.00% → -49.68%)
High-resolution chart · PNG

NVAX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Novavax Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-72.3169%
-180.7161%
-490.8283%
-352.576%
-318.2078%
-262.5967%
-350%
-685.7143%
-550%
-816.6667%
-700%
-537.5%
-600%
-600%
-733.3333%
-1,700%
-1,633.3333%
-1,600%
-1,600%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.